143 related articles for article (PubMed ID: 31678283)
21. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
[TBL] [Abstract][Full Text] [Related]
22. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 in liver toxicology.
Taguchi K; Kensler TW
Arch Pharm Res; 2020 Mar; 43(3):337-349. PubMed ID: 31782059
[TBL] [Abstract][Full Text] [Related]
24. New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.
Kobayashi A; Waku T
Cancer Sci; 2020 Jan; 111(1):6-14. PubMed ID: 31742837
[TBL] [Abstract][Full Text] [Related]
25. Binding partners of NRF2: Functions and regulatory mechanisms.
Nam LB; Keum YS
Arch Biochem Biophys; 2019 Dec; 678():108184. PubMed ID: 31733215
[TBL] [Abstract][Full Text] [Related]
26. The KEAP1-NRF2 System as a Molecular Target of Cancer Treatment.
Taguchi K; Yamamoto M
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375248
[TBL] [Abstract][Full Text] [Related]
27. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
[TBL] [Abstract][Full Text] [Related]
28. Ferroptosis in Liver Diseases: An Overview.
Capelletti MM; Manceau H; Puy H; Peoc'h K
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664576
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk between NRF2 and Dicer through metastasis regulating MicroRNAs; mir-34a, mir-200 family and mir-103/107 family.
Nabih HK
Arch Biochem Biophys; 2020 Jun; 686():108326. PubMed ID: 32142889
[TBL] [Abstract][Full Text] [Related]
30. NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis.
Robertson H; Dinkova-Kostova AT; Hayes JD
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33276631
[TBL] [Abstract][Full Text] [Related]
31. Oxidative Stress in Cancer.
Hayes JD; Dinkova-Kostova AT; Tew KD
Cancer Cell; 2020 Aug; 38(2):167-197. PubMed ID: 32649885
[TBL] [Abstract][Full Text] [Related]
32. The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance.
Choi BH; Kim JM; Kwak MK
Arch Pharm Res; 2021 Mar; 44(3):263-280. PubMed ID: 33754307
[TBL] [Abstract][Full Text] [Related]
33. NRF2 in human neoplasm: Cancer biology and potential therapeutic target.
Liu Y; Lang F; Yang C
Pharmacol Ther; 2021 Jan; 217():107664. PubMed ID: 32810525
[TBL] [Abstract][Full Text] [Related]
34. Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype.
Hallis SP; Kim JM; Kwak MK
Mol Cells; 2023 Mar; 46(3):153-164. PubMed ID: 36994474
[TBL] [Abstract][Full Text] [Related]
35. YES1 as a potential target to overcome drug resistance in EGFR-deregulated non-small cell lung cancer.
Kook E; Lee J; Kim DH
Arch Toxicol; 2024 May; 98(5):1437-1455. PubMed ID: 38443724
[TBL] [Abstract][Full Text] [Related]
36. An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness.
Peng H; Feng K; Jia W; Li Y; Lv Q; Zhang Y
Apoptosis; 2024 Jun; 29(5-6):898-919. PubMed ID: 38411862
[TBL] [Abstract][Full Text] [Related]
37. Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review.
Fakhrioliaei A; Tanhaei S; Pakmehr S; Noori Shakir M; Qasim MT; Hariri M; Nouhi Kararoudi A; Valilo M
J Membr Biol; 2024 Apr; 257(1-2):3-16. PubMed ID: 38356054
[TBL] [Abstract][Full Text] [Related]
38. Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review.
Moubarak MM; Pagano Zottola AC; Larrieu CM; Cuvellier S; Daubon T; Martin OCB
Neurooncol Adv; 2024; 6(1):vdad160. PubMed ID: 38221979
[TBL] [Abstract][Full Text] [Related]
39. Biology-driven therapy advances in high-grade serous ovarian cancer.
Wang Y; Duval AJ; Adli M; Matei D
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 38165032
[TBL] [Abstract][Full Text] [Related]
40. Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions.
Nguyen TH; Nguyen TM; Ngoc DTM; You T; Park MK; Lee CH
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
